Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The histomorphologic criteria for the pathological features of liver tissue from patients with non-alcoholic fatty liver disease (NAFLD) remain subjective, causing confusion among pathologists and clinicians. In this report, we studied interobserver agreement of NAFLD pathologic features and analyzed causes of disagreement. Methods: Thirty-one cases of clinicopathologically diagnosed NAFLD from 10 hospitals were selected. One hematoxylin and eosin and one Masson’s trichrome-stained virtual slide from each case were blindly reviewed with regard to 12 histological parameters by 13 pathologists in a gastrointestinal study group of the Korean Society of Pathologists. After the first review, we analyzed the causes of disagreement and defined detailed morphological criteria. The glass slides from each case were reviewed a second time after a consensus meeting. The degree of interobserver agreement was determined by multi-rater kappa statistics. Results: Kappa values of the first review ranged from 0.0091–0.7618. Acidophilic bodies (k = 0.7618) and portal inflammation (k = 0.5914) showed high levels of agreement, whereas microgranuloma (k = 0.0984) and microvesicular fatty change (k = 0.0091) showed low levels of agreement. After the second review, the kappa values of the four major pathological features increased from 0.3830 to 0.5638 for steatosis grade, from 0.1398 to 0.2815 for lobular inflammation, from 0.1923 to 0.3362 for ballooning degeneration, and from 0.3303 to 0.4664 for fibrosis. Conclusions: More detailed histomorphological criteria must be defined for correct diagnosis and high interobserver agreement of NAFLD.
Abstract
Background: The histomorphologic criteria for the pathological features of liver tissue from patients with non-alcoholic fatty liver disease (NAFLD) remain subjective, causing confusion among pathologists and clinicians. In this report, we studied interobserver agreement of NAFLD pathologic features and analyzed causes of disagreement. Methods: Thirty-one cases of clinicopathologically diagnosed NAFLD from 10 hospitals were selected. One hematoxylin and eosin and one Masson’s trichrome-stained virtual slide from each case were blindly reviewed with regard to 12 histological parameters by 13 pathologists in a gastrointestinal study group of the Korean Society of Pathologists. After the first review, we analyzed the causes of disagreement and defined detailed morphological criteria. The glass slides from each case were reviewed a second time after a consensus meeting. The degree of interobserver agreement was determined by multi-rater kappa statistics. Results: Kappa values of the first review ranged from 0.0091–0.7618. Acidophilic bodies (k = 0.7618) and portal inflammation (k = 0.5914) showed high levels of agreement, whereas microgranuloma (k = 0.0984) and microvesicular fatty change (k = 0.0091) showed low levels of agreement. After the second review, the kappa values of the four major pathological features increased from 0.3830 to 0.5638 for steatosis grade, from 0.1398 to 0.2815 for lobular inflammation, from 0.1923 to 0.3362 for ballooning degeneration, and from 0.3303 to 0.4664 for fibrosis. Conclusions: More detailed histomorphological criteria must be defined for correct diagnosis and high interobserver agreement of NAFLD.
참고문헌 (21)
- Brunt EM, "Pathology of steatohepatitis", Best Pract Res Clin Gastroenterol, 16, pp.691~707 (2002)
- Lee RG, "Nonalcoholic steatohepatitis: a study of 49 patients", Hum Pathol, 20, pp.594~598 (1989)
- Powell EE, "The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years", Hepatology, 11, pp.74~80 (1990)
- Teli MR, "The natural history of nonalcoholic fatty liver: a follow-up study", Hepatology, 22, pp.1714~1719 (1995)
- Ong JP, "Epidemiology and natural history of NAFLD and NASH", Clin Liver Dis, 11, pp.1~16 (2007)
- Dunn W, "Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study", Am J Gastroenterol, 103, pp.2263~2271 (2008)
- Ong JP, "Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease", J Hepatol, 49, pp.608~612 (2008)
- Carter-Kent C, "Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study", Hepatology, 50, pp.1113~1120 (2009)
- Musso G, "A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease", Hepatology, 52, pp.79~104 (2010)
- Starley BQ, "Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection", Hepatology, 51, pp.1820~1832 (2010)
- Abrams GA, "Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease", Hepatology, 40, pp.475~483 (2004)
- Adams LA, "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", J Hepatol, 42, pp.132~138 (2005)
- Xanthakos S, "Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents", Clin Gastroenterol Hepatol, 4, pp.226~232 (2006)
- Brunt EM, "Pathology of nonalcoholic fatty liver disease", Rev Gastroenterol Hepatol, 7, pp.195~203 (2010)
- Kleiner DE, "Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research", Semin Liver Dis, 32, pp.3~13 (2012)
- Brunt EM, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
- Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
- Ludwig J, "Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease", Mayo Clin Proc, 55, pp.434~438 (1980)
- Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", Gastroenterology, 116, pp.1413~1419 (1999)
- Promrat K, "A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis", Hepatology, 39, pp.188~196 (2004)
- Yeh MM, "Pathology of nonalcoholic fatty liver disease", Am J Clin Pathol, 128, pp.837~847 (2007)